MEDICAL TREATMENT OF METASTATIC MELANOMA
- 1 December 1996
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 76 (6) , 1343-1354
- https://doi.org/10.1016/s0039-6109(05)70519-3
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Intermittent interferon and polychemotherapy in metastatic melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Interferon alpha2a and vindesine in the treatment of advanced malignant melanomaEuropean Journal Of Cancer, 1992
- A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaEuropean Journal Of Cancer, 1992
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Interim Report of Phase II Study of New Nitrosourea S 10036 in Disseminated Malignant MelanomaJNCI Journal of the National Cancer Institute, 1988
- Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanomaCancer, 1988
- Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: Three consecutive phase II trialsEuropean Journal of Cancer and Clinical Oncology, 1985
- Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyEuropean Journal of Cancer and Clinical Oncology, 1982
- A multicentre phase II trial of vindesine in malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1982
- Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cellsZeitschrift für Die Gesamte Experimentelle Medizin, 1982